Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-24

Clinical Trial Update: Midodrine Use in Septic Shock [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating midodrine for septic shock was terminated; results were posted on 2025-09-24.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Midodrine (Midodrine)

Snippet

Sponsor: University of Virginia | Conditions: Septic Shock | Phase 3 | Status: TERMINATED | Results posted: 2025-09-24